Stockreport

Oragenics, Inc. to Present Interim Data on AG013 at the European Society of Medical Oncology Congress

Oragenics Inc.  (OGEN) 
NASDAQ:AMEX Investor Relations: ir.oragenics.com
PDF TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatmen [Read more]